يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Lipatov Oleg"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Schmid, Peter; Lipatov, Oleg; Im, Seock-Ah; Goncalves, Anthony; Muñoz-Couselo, Eva; Lee, Keun Seok; Tamura, Kenji; Testa, Laura; Witzel, Isabell; Ohtani, Shoichiro; Turner, Nicholas; Zambelli, Stefania; Harbeck, Nadia; Andre, Fabrice; Dent, Rebecca; Mejia, Jaime A; Zhou, Xuan; Haiderali, Amin; Nguyen, Allison Martin; Cortes, Javier; Winer, Eric P (2023). Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study. European Journal of Cancer, 195:113393.

    وصف الملف: application/pdf

    العلاقة: https://www.zora.uzh.ch/id/eprint/256039/1/ZORA_256039.pdfTest; info:pmid/37976633; urn:issn:0959-8049

  2. 2
    دورية أكاديمية

    المصدر: Cameron, David; Brown, Julia; Dent, Rebecca; Jackisch, Christian; Mackey, John; Pivot, Xavier; Steger, Guenther G.; Suter, Thomas M.; Toi, Masakazu; Parmar, Mahesh; Laeufle, Rita; Im, Young-Hyuck; Romieu, Gilles; Harvey, Vernon; Lipatov, Oleg; Pienkowski, Tadeusz; Cottu, Paul; Chan, Arlene; Im, Seock-Ah; Hall, Peter S.; . (2013). Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial. The lancet oncology, 14(10), pp. 933-942. Elsevier 10.1016/S1470-2045(13)70335-8

    مصطلحات موضوعية: 610 Medicine & health